Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,865 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Enhanced Antitumor Effect in Liver Cancer by Amino Acid Depletion-Induced Oxidative Stress.
Okuda K, Umemura A, Kataoka S, Yano K, Takahashi A, Okishio S, Taketani H, Seko Y, Nishikawa T, Yamaguchi K, Moriguchi M, Nakagawa H, Liu Y, Mitsumoto Y, Kanbara Y, Shima T, Okanoue T, Itoh Y. Okuda K, et al. Front Oncol. 2021 Nov 2;11:758549. doi: 10.3389/fonc.2021.758549. eCollection 2021. Front Oncol. 2021. PMID: 34796113 Free PMC article.
Combination of PNPLA3 and TLL1 polymorphism can predict advanced fibrosis in Japanese patients with nonalcoholic fatty liver disease.
Seko Y, Yamaguchi K, Mizuno N, Okuda K, Takemura M, Taketani H, Hara T, Umemura A, Nishikawa T, Moriguchi M, Yasui K, Kamaguchi M, Nishioji K, Mochizuki N, Kobayashi M, Mori K, Tanaka S, Matsuura K, Tanaka Y, Itoh Y. Seko Y, et al. Among authors: okuda k. J Gastroenterol. 2018 Mar;53(3):438-448. doi: 10.1007/s00535-017-1372-8. Epub 2017 Jul 25. J Gastroenterol. 2018. PMID: 28744823
Impact of Insufficient Response with an Increase in Tumor Number in Predicting Transcatheter Arterial Chemoembolization Refractoriness for Hepatocellular Carcinoma.
Furuta M, Moriguchi M, Okuda K, Kataoka S, Mizuno N, Takemura M, Taketani H, Hara T, Seko Y, Umemura A, Nishikawa T, Yamaguchi K, Yasui K, Minami M, Itoh Y. Furuta M, et al. Among authors: okuda k. Dig Dis. 2018;36(5):385-394. doi: 10.1159/000489488. Epub 2018 Jul 3. Dig Dis. 2018. PMID: 29969764
Hepatitis C virus eradication prolongs overall survival in hepatocellular carcinoma patients receiving molecular-targeted agents.
Seko Y, Moriguchi M, Takahashi A, Yamaguchi K, Umemura A, Okuda K, Kataoka S, Unozawa H, Kobayashi K, Ogasawara S, Sato R, Tsuchiya S, Watanabe S, Morimoto N, Iwai K, Aramaki T, Kato N, Itoh Y. Seko Y, et al. Among authors: okuda k. J Gastroenterol. 2022 Feb;57(2):90-98. doi: 10.1007/s00535-021-01837-5. Epub 2022 Jan 15. J Gastroenterol. 2022. PMID: 35031857
Potential Therapeutic Targets and Promising Agents for Combating NAFLD.
Umemura A, Kataoka S, Okuda K, Seko Y, Yamaguchi K, Moriguchi M, Okanoue T, Itoh Y. Umemura A, et al. Among authors: okuda k. Biomedicines. 2022 Apr 14;10(4):901. doi: 10.3390/biomedicines10040901. Biomedicines. 2022. PMID: 35453652 Free PMC article. Review.
2,865 results